ClinicalTrials.Veeva

Menu

ORN Study: Curative Treatment of Osteoradionecrosis (ORN) With Hybrid Bone Substitution

N

Nantes University Hospital (NUH)

Status

Completed

Conditions

Osteoradionecrosis
Mandible

Treatments

Procedure: Hybrid bone substitution

Study type

Interventional

Funder types

Other

Identifiers

NCT01147315
BRD/08/10-H

Details and patient eligibility

About

The main objective of the study is the cure of osteoradionecrosis (ORN) at 12 months.

Enrollment

13 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (between 18 and 75 years) affiliated with an appropriate social security system, diagnosed as suffering from symptomatic ORN, radiologically confirmed, for which surgery is indicated
  • Presence maximum of 2 outbreaks of ORN
  • Oncological remission of the original tumor site for 1 year and for 3 years if the ORN is in the contact or close to the initial tumoral site
  • ECOG performance status 0, 1 or 2
  • ORN symptomatic accessible to the conservation of at least one cortical mandibular basilar
  • Signed informed consent

Exclusion criteria

  • Oncological treatment
  • Haematologic background
  • Current bone necrosis consecutive or concurrent to taking bisphosphonates
  • Extension of ORN does not allow the retention of a mandibular rod (bicortical form)
  • Presence of fracture complicating ORN
  • Bisphosphonates during the last year
  • Contraindications to the removal of iliac or sternum bone marrow
  • Contraindication for general anesthesia

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

13 participants in 1 patient group

Hybrid bone substitution
Experimental group
Description:
Hybrid bone substitution with calcium-phosphate ceramic biomaterial and autologous bone marrow
Treatment:
Procedure: Hybrid bone substitution

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems